The Complex Rehab Technology (CRT) and broader DME communities are navigating a period of heightened policy volatility, budget pressure, and evolving regulatory priorities. While advocacy efforts have yielded important wins, the past few years have underscored a central truth: sustained, coordinated advocacy remains essential to protecting patient access, provider viability, and innovation across the care continuum. This session will examine the current advocacy landscape, highlighting key challenges encountered over the past year and those anticipated in 2026. Attendees will gain insight into federal and state policy trends, funding dynamics, and regulatory pressures shaping the future of the industry. The presentation will also explore how advocacy intersects with manufacturing, provider operations, and patient outcomes. Designed for manufacturers, providers, clinicians, and industry partners, this discussion will move beyond theory to focus on practical engagement. Participants will leave with a clearer understanding of where advocacy efforts matter most and how stakeholders at every level can play an active role in shaping policy outcomes. Key Topics Covered •Why ongoing advocacy is critical for Complex Rehab Technology and DME •Major policy, reimbursement, and funding challenges faced in the past year •Anticipated healthcare policy and budget developments in 2026 •The role of manufacturers, providers, clinicians, and suppliers in advocacy efforts •Practical ways stakeholders can engage with policymakers and regulators •Building consistent, credible relationships with legislative and regulatory offices